Member Info for Gord_1

Surely the sellers will run out at this price and the BB and Kestrel will have to pay a premium? I'm finding it difficult to understand who is selling in the volumes being bought. Pis are selling but Pi's are also buying. Any more thoughts anyone? Also why would a ii sell at this price too if a takeover was looming....its bit bonkers whats going on here tbh.

The last reported transaction volume on the GS20 platform was on a H1 interim report to Sept 23. For those 6 months it was $21M. Has any volume reports ever been produced since as I cant see it in the annual report for 23. ? Just trying to determine progress of this platform.....

So that's around ~$7M revenue if the average volume is only 25% of today's volume. OMG !

X by 250 trading days = $20M , but lets be conservative and say 25% = $5M revenue . This is more than total of last year and excludes all other assets ....happy days if this continues !

Do you think these will still happen? and how their purchase will be funded? May be they need to clarify on these before the SP increases? imo

Brokers don't really have a clue and maybe have their own agenda, for example on another stock highlighted on another board

Last Friday : Bank of America sunk the shares by 4% with "under-perform".

Today : Citi reiterates 'buy' rating on same stock.

Tomorrow : who knows...they might get bought out .....but the UK needs houses and VTY are in a great position to deliver.

Nice website , only thing I would change is they state specifically 2000 satisfied clients which could be implied as small base. Perhaps say : "Thousands of satisfied clients" and not be specific as this number is dynamic ?

I'm puzzled by this share......is it going anywhere as it seems they raised a lot of money somehow at 9p and its now just stuck at this level below 7p. Is there any good news on the horizon as it seems to have just halted ? I'm not being negative but where is this going ?

If PFC go bust with all those contracts to service ....would this be an opportunity for Wood....or do they service a different market ? Who would benefit if PFC collapsed ?

Any thoughts on how long the phase 1 trial will last ?

Do you have a link to this please ? If a bid was coming in , what price do you think would be offered?

I agree

At 400:1 , the way things are going...this could be back in the penny stock shortly after consolidation.

To be fair, its not as bad as the VAST Consolidation....yet :-) (£100 invested in VAST 3 years ago and after 2 consolidations, is now worth less than 50p). Different business but same funding principle as HEMO sadly.

Great science if proven, but the business model and treatment of LTH's stinks right now imo.

Sadly that's the issue here , science might be good , but until this is resolved its not looking ideal for pi's . I really feel that HEMO should tell us whats really going on as the trial has not formally started yet , only that approval has been given to proceed.

The potential is binary ...either it works or not. I hope it does as the benefits will be huge. Sadly i think the cash has run out ( or about too) thus funding needs to be confirmed asap as its unfair to leave this simply to pi's by placing huge discounts on the SP. It needs a injection from a ii who doesn't flip or a major Pharma and maybe that's the goal from consolidation in the long term. In the meantime its gong to be a rocky ride.

I'm voting Yes.....any company who is dedicated on developing science that will potentially save lives ....is worth backing. It will pay off massively in the long run if this venture is successful. I understand the difficulties this company has had on the LSE so lets help get them out of that bubble.

The LSE is no place really to just fund a program like this. Its got lengthy timescales and the SP has been floating around above the nominal value for months despite good progress being made. Despite the pump and Previal announcements to try and get it way above the nominal value to attract investors, it still gets hammered by the shorter's and MM's. Any good progress is taken down by a consolidation announcement to below par again. Any raise to help them finance the program has to be done at a huge discount as the current investors want their pound of flesh. Bit of a mess trying to raise funds on the LSE and it hits hard on LTH's who believe in this program. Maybe such drastic action was necessary to attract a different kind of investor and provide SP stability in the long run, well above the nominal value. IMO they should try to get the endorsement from a major Pharma as this SP would be long gone if they did. It would be far easier to raise funds if it was known that a major Pharma was watching this. Just a thought Vlad ;-) and his marketing team.

I'm sure you are all aware that the LSE is technically ducked for companies wishing to raise funds for leading edge developments. Its also ducked for established companies who provide a sniff of a small profit warning. I have seen multi-billion companies recently loose half the share value based upon minor announcements, I'm not sure why but any announcements generally on the LSE can loose huge % on share price and don't warrant it. For example VTY and Wood lost billions, whilst the business model being sound and order books good they announced that they needed to do some internal audits to verify some financials and lost half their value in the process. Billions, not millions. The US market is more stable hence why so many companies are moving there.

As for HEMO, they need to raise cash for this development. I think the Prevail investment was an attempt to pump up the share price buy it didn't work. I suspect the £600K recent "investment" was to pay Prevail for their services ( it was a placing in disguise imo) .....as the shares issued to them last year for the trial are now worth 6 times less than the original investment. They were probably hoping the SP would be much higher by now leading up to the trial.

Going forward , if HEMO don't get one of the pharma's on board or listed on the US market or some form of development grant, they will have to keep coming back to the pi's via placings. I don't think a ii would invest at this stage as there is still a lot of cash needed to get this to a point of success and any investment would be a big gamble for a ii. Not sure how this is going to end up TBH if funded only by pi's on the UK LSE.

One was mine (as its exact amount of shares) I bought ........but it came up as a sell.